Literature DB >> 4860823

Immunologic studies in a patient sensitive to tetracycline and penicillin.

M J Fellner, R L Baer.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1966        PMID: 4860823     DOI: 10.1007/BF00517846

Source DB:  PubMed          Journal:  Arch Klin Exp Dermatol        ISSN: 0300-8614


× No keyword cloud information.
  15 in total

1.  PENICILLIN ALLERGY: ITS DETECTION BY AN IMPROVED HAEMAGGLUTINATION TECHNIQUE.

Authors:  A L DE WECK
Journal:  Nature       Date:  1964-06-06       Impact factor: 49.962

2.  SEROLOGIC STUDIES ON PENICILLIN HYPERSENSITIVITY IN HUMAN BEINGS.

Authors:  J P MCGOVERN; C D DUKES; R G WAGELIE
Journal:  Ann Allergy       Date:  1964-05

3.  IMMUNOLOGIC RESPONSIVENESS OF MAN TO PENICILLIN.

Authors:  R H SCHWARTZ; J H VAUGHAN
Journal:  JAMA       Date:  1963-12-28       Impact factor: 56.272

4.  SLOWLY SEDIMENTING MERCAPTOETHANOL-RESISTANT ANTINUCLEAR FACTORS RELATED ANTIGENICALLY TO M IMMUNOGLOBULINS (GAMMA-1M-GLOBULIN) IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS.

Authors:  N F ROTHFIELD; B FRANGIONE; E C FRANKLIN
Journal:  J Clin Invest       Date:  1965-01       Impact factor: 14.808

5.  Immediate reactions in the skin of experimental animals provoked by antibody-antigen interaction.

Authors:  Z OVARY
Journal:  Prog Allergy       Date:  1958

6.  Response of lymphocytes to tetracycline.

Authors:  C S Ripps; M J Fellner; K Hirschhorn
Journal:  Lancet       Date:  1965-11-06       Impact factor: 79.321

7.  Benzylpenicilloyl specific serum antibodies to penicillin in man. I. Development of a sensitive hemagglutination assay method and haptenic specificities of antibodies.

Authors:  B B Levine; M J Fellner; V Levytska
Journal:  J Immunol       Date:  1966-04       Impact factor: 5.422

8.  A NEW CLASS OF HUMAN IMMUNOGLOBULINS. II. NORMAL SERUM IGD.

Authors:  D S ROWE; J L FAHEY
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

9.  The association of skin-sensitizing antibody with the beta 2A-globulins in sera from ragweed-sensitive patients.

Authors:  P FIREMAN; W E VANNIER; H C GOODMAN
Journal:  J Exp Med       Date:  1963-04-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.